Literature DB >> 8116740

The effect of long-term medical therapy on the outcome of filtration surgery.

D H Johnson1, K Yoshikawa, R F Brubaker, D O Hodge.   

Abstract

Long-term medical therapy and laser trabeculoplasty have been implicated as risk factors in the outcome of glaucoma filtration surgery. A retrospective analysis was performed of patients undergoing primary trabeculectomy during three key periods: before use of beta-blockers and laser trabeculoplasty (1975 and 1976), after introduction of beta-blocker therapy but before use of the laser (1980), and after common use of beta-blockers and laser (1985 and 1986). A total of 150 patients were included in the analysis. Eyes treated with laser trabeculoplasty at some time before filtration surgery had a decreased probability of successful filtration surgery (intraocular pressure less than 21 mm Hg, 75% vs 91% at one year, P = .05; 50% vs 86% at five years, P = .01). It is unknown whether laser was detrimental to subsequent filtration surgery or merely acted as a selection factor in identifying patients who would have less successful surgical outcomes. Preoperative use of topical medication did not influence the outcome of surgery. Patients having bilateral filtration surgery had similar outcomes between fellow eyes despite the longer use of therapy in the second eye (mean of 1.8 years between operations). In the subgroup of eyes with low preoperative intraocular pressures (less than 21 mm Hg), surgery was successful in reducing pressure to a lower level in 70% of eyes at one year (preoperative pressure, 17.8 mm; one-year postoperative pressure, 13.3 mm, P = .007).

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8116740     DOI: 10.1016/s0002-9394(14)73068-5

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  10 in total

1.  Membrane formation in the chamber angle after failure of argon laser trabeculoplasty: analysis of risk factors.

Authors:  T Koller; J Stürmer; C Remé; B Gloor
Journal:  Br J Ophthalmol       Date:  2000-01       Impact factor: 4.638

2.  Long-term results of trabeculectomy in eyes that were initially successful.

Authors:  J T Wilensky; T C Chen
Journal:  Trans Am Ophthalmol Soc       Date:  1996

3.  Risk factors for failures of trabeculectomies performed without antimetabolites.

Authors:  H Mietz; B Raschka; G K Krieglstein
Journal:  Br J Ophthalmol       Date:  1999-07       Impact factor: 4.638

4.  Early conjunctival changes following treatment with metipranolol and preservatives are not reversible with dexamethasone.

Authors:  H Mietz; U Schlötzer-Schrehardt; J H Lemke; G K Krieglstein
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-07       Impact factor: 3.117

Review 5.  Does medical treatment influence the success of trabeculectomy?

Authors:  Allan Joseph Flach
Journal:  Trans Am Ophthalmol Soc       Date:  2004

6.  Two-Year Comparative Outcomes of First- and Second-Generation Trabecular Micro-Bypass Stents with Cataract Surgery.

Authors:  Ricardo Augusto Paletta Guedes; Daniela Marcelo Gravina; Vanessa Maria Paletta Guedes; Alfredo Chaoubah
Journal:  Clin Ophthalmol       Date:  2021-05-05

7.  Efficacy and patient tolerability of travoprost BAK-free solution in patients with open-angle glaucoma and ocular hypertension.

Authors:  Sophia K Mirza; Sandra M Johnson
Journal:  Clin Ophthalmol       Date:  2010-08-09

8.  Topical Steroids and Glaucoma Filtration Surgery Outcomes: An In Vivo Confocal Study of the Conjunctiva.

Authors:  Leonardo Mastropasqua; Lorenza Brescia; Francesca D'Arcangelo; Mario Nubile; Giada D'Onofrio; Michele Totta; Fabiana Perna; Raffaella Aloia; Luca Agnifili
Journal:  J Clin Med       Date:  2022-07-07       Impact factor: 4.964

Review 9.  How ocular surface disease impacts the glaucoma treatment outcome.

Authors:  Snježana Kaštelan; Martina Tomić; Kata Metež Soldo; Jasminka Salopek-Rabatić
Journal:  Biomed Res Int       Date:  2013-10-09       Impact factor: 3.411

10.  The Effects of 3% Diquafosol Sodium Eye Drops on Tear Function and the Ocular Surface of Cu, Zn-Superoxide Dismutase-1 (Sod1) Knockout Mice Treated with Antiglaucoma Eye Medications.

Authors:  Yukari Yagi-Yaguchi; Takashi Kojima; Kazunari Higa; Murat Dogru; Osama Ma Ibrahim; Takahiko Shimizu; Kazuo Tsubota; Jun Shimazaki
Journal:  Diagnostics (Basel)       Date:  2020-01-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.